Search research articles
Contact Us
Filters
Showing results (91-100 of 128) with videos related to
Page
of 13
Sort By:
Nucleic Acids Research
|
December 8, 2025
Enzyme Engineering Database (EnzEngDB): a platform for sharing and interpreting sequence-function relationships across protein engineering campaigns
Yueming Long, Fatemeh Abbasinejad, Francesca-Zhoufan Li, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
September 6, 2023
Survival Benefit Relative to Treatment Modalities Among Patients with Very Early Intrahepatic Cholangiocarcinoma: an Analysis of the National Cancer Database
Yutaka Endo, Kazunari Sasaki, Muhammad Musaab Munir, et al.
Surgery
|
September 24, 2023
Liver transplantation access and outcomes: Impact of variations in liver-specific specialty care
Yutaka Endo, Kazunari Sasaki, Zorays Moazzam, et al.
JCI Insight
|
July 13, 2018
Antibody-modified conduits for highly selective cytokine elimination from blood
J Brian McAlvin, Ryan G Wylie, Krithika Ramchander, et al.
Cancer
|
June 7, 2023
Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer
Qing Zhou, Jun Zhao, Jianhua Chang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 8, 2022
Biologic correlates of beneficial convalescent plasma therapy in a COVID-19 patient reveal disease resolution mechanisms
Natalie Bruiners, Valentina Guerrini, Rahul Ukey, et al.
Human Genetics
|
May 6, 2020
An exome-first approach to aid in the diagnosis of primary ciliary dyskinesia
Hanan E Shamseldin, Ibrahim Al Mogarri, Mansour M Alqwaiee, et al.
Endocrine-Related Cancer
|
January 23, 2024
Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients
Xiangqian Zheng, Meiyu Fang, Yun Fan, et al.
The Lancet. Oncology
|
January 17, 2022
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
Caicun Zhou, Ziping Wang, Yuping Sun, et al.
JAMA
|
February 24, 2025
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical Trial
Xiaotian Zhang, Jufeng Wang, Gang Wang, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 128) with videos related to
Sort By:
Page
of 13
Nucleic Acids Research
|
December 8, 2025
Enzyme Engineering Database (EnzEngDB): a platform for sharing and interpreting sequence-function relationships across protein engineering campaigns
Yueming Long, Fatemeh Abbasinejad, Francesca-Zhoufan Li, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
September 6, 2023
Survival Benefit Relative to Treatment Modalities Among Patients with Very Early Intrahepatic Cholangiocarcinoma: an Analysis of the National Cancer Database
Yutaka Endo, Kazunari Sasaki, Muhammad Musaab Munir, et al.
Surgery
|
September 24, 2023
Liver transplantation access and outcomes: Impact of variations in liver-specific specialty care
Yutaka Endo, Kazunari Sasaki, Zorays Moazzam, et al.
JCI Insight
|
July 13, 2018
Antibody-modified conduits for highly selective cytokine elimination from blood
J Brian McAlvin, Ryan G Wylie, Krithika Ramchander, et al.
Cancer
|
June 7, 2023
Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer
Qing Zhou, Jun Zhao, Jianhua Chang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 8, 2022
Biologic correlates of beneficial convalescent plasma therapy in a COVID-19 patient reveal disease resolution mechanisms
Natalie Bruiners, Valentina Guerrini, Rahul Ukey, et al.
Human Genetics
|
May 6, 2020
An exome-first approach to aid in the diagnosis of primary ciliary dyskinesia
Hanan E Shamseldin, Ibrahim Al Mogarri, Mansour M Alqwaiee, et al.
Endocrine-Related Cancer
|
January 23, 2024
Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients
Xiangqian Zheng, Meiyu Fang, Yun Fan, et al.
The Lancet. Oncology
|
January 17, 2022
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
Caicun Zhou, Ziping Wang, Yuping Sun, et al.
JAMA
|
February 24, 2025
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical Trial
Xiaotian Zhang, Jufeng Wang, Gang Wang, et al.
Page
of 13